NCT00641693View on ClinicalTrials.gov

Assess the Efficacy and Safety of Rhinocort Aqua

PHASE2CompletedINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Allergic Rhinitis

Interventions

DRUG

Budesonide

16mg Nasal Spray

DRUG

Budesonide

32mg Nasal Spray

DRUG

Budesonide

64mg Nasal Spray

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY